KATENDI KANEMA: Open Payments
NPI 1609533298 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 7 payments from 5 companies in 2025. Trend: 2023 $725 · 2024 $296 · 2025 $437
Food & beverage: $325Education: $111
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Teva Pharmaceuticals USA, Inc. | 2 | $125 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Corium, LLC | 1 | $14 |
Products named: CAPLYTA, SPRAVATO, INGREZZA, Azstarys, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
